Lisanti Capital Growth, LLC Procept Bio Robotics Corp Transaction History
Lisanti Capital Growth, LLC
- $371 Million
- Q4 2024
A detailed history of Lisanti Capital Growth, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 40,685 shares of PRCT stock, worth $2.53 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
40,685
Previous 60,965
33.26%
Holding current value
$2.53 Million
Previous $4.88 Million
32.93%
% of portfolio
0.88%
Previous 1.42%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$217 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$109 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$92.8 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$75.1 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.78B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...